for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CellaVision AB

CEVI.ST

Latest Trade

348.50SEK

Change

-1.50(-0.43%)

Volume

14,647

Today's Range

347.00

 - 

353.00

52 Week Range

185.00

 - 

409.50

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
350.00
Open
353.00
Volume
14,647
3M AVG Volume
0.95
Today's High
353.00
Today's Low
347.00
52 Week High
409.50
52 Week Low
185.00
Shares Out (MIL)
23.85
Market Cap (MIL)
8,348.04
Forward P/E
72.09
Dividend (Yield %)
0.43

Next Event

Q3 2019 CellaVision AB Earnings Call

Latest Developments

More

CellaVision Completes Acquisition Of RAL Diagnostics

Cellavision AB Says Co To Acquire RAL Diagnostics

CellaVision Q2 Operating Profit Up At SEK 112.4 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CellaVision AB

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

Industry

Medical Equipment & Supplies

Contact Info

Mobilvagen 12

+46.46.4601600

http://www.cellavision.com

Executive Leadership

Soren Mellstig

Independent Chairman of the Board

Zlatko Rihter

President, Chief Executive Officer

Magnus Blixt

Chief Financial Officer

Mattias Lundin

Vice President Global Sales

Peter Wilson

Vice President Global Marketing

Key Stats

3.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, SEK)

2017

0.3K

2018

0.4K

2019(E)

0.5K
EPS (SEK)

2017

2.920

2018

3.720

2019(E)

4.855
Price To Earnings (TTM)
80.30
Price To Sales (TTM)
20.28
Price To Book (MRQ)
26.94
Price To Cash Flow (TTM)
73.48
Total Debt To Equity (MRQ)
9.19
LT Debt To Equity (MRQ)
7.10
Return on Investment (TTM)
35.21
Return on Equity (TTM)
28.67

Latest News

Latest News

BRIEF-CellaVision Q1 Operating Profit Falls To SEK 23.2 Million

* Q1 OPERATING PROFIT SEK 23.2 MILLION VERSUS SEK 34.3 MILLION YEAR AGO

BRIEF-Cellavision AB Q4 Net Sales Up At Sek ‍76.1​ Million

* Q4 NET SALES SEK 76.1 MILLION VERSUS SEK 72.8 MILLION YEAR AGO

BRIEF-Cellavision Q3 operating profit falls to SEK ‍10.2​ mln

* Q3 NET SALES SEK 61.3 MILLION VERSUS SEK 68.3 MILLION YEAR AGO

BRIEF-Cellavision Q1 oper profit SEK 34.3 million

* Q1 OPERATING PROFIT SEK 34.3 MILLION VERSUS SEK 13.9 MILLION YEAR AGO

BRIEF-Cellavision prelim Q1 net sales over SEK 93 mln

* REG-CELLAVISION QUANTIFIES THE OUTLOOK FOR THE FIRST QUARTER OF 2017

BRIEF-Cellavision Q4 operating profit rises to SEK 21.6 mln

* Q4 net sales 72.8 million Swedish crowns ($8.21 million) versus 61.6 million crowns year ago

BRIEF-Cellavision Q3 operating profit falls to SEK 19.5 mln

* Q3 net sales 68.3 million Sweden crowns ($7.67 million) versus 74.5 million crowns year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up